Humana EBITDA 2012-2026 | HUM | MacroTrends

Humana EBITDA 2012-2026 | HUM

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Humana EBITDA for the quarter ending March 31, 2026 was $604M, a 37.8% decline year-over-year.

Humana 2024 EBITDA was 3.53B, a 28.4% decline from 2023.
Humana 2023 EBITDA was 4.93B, a 6.14% increase from 2022.
Humana 2022 EBITDA was 4.645B, a 20.31% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Humana EBITDA 2012-2026 | HUM

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Humana 2024 EBITDA was 3.53B, a 28.4% decline from 2023.
Humana 2023 EBITDA was 4.93B, a 6.14% increase from 2022.
Humana 2022 EBITDA was 4.645B, a 20.31% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
UnitedHealth Group (UNH)	$276.2B
Cigna Group (CI)	$71.5B
Centene (CNC)	$18.3B
Molina Healthcare (MOH)	$7.6B
Select Medical Holdings (SEM)	$2B
Joint (JYNT)	$125M
Aethlon Medical (AEMD)	$3M